Your browser is no longer supported. Please, upgrade your browser.
HomeNewsScreenerMapsGroupsPortfolioInsiderFuturesForexCryptoBacktestsElite Help
publish chart | save to portfolio | create alert Type: candle | line | advanced | interactive | perf    Timeframe: intraday | daily | weekly | monthly  Settings
ABIO ARCA biopharma, Inc. daily Stock Chart
ABIO [NASD]
ARCA biopharma, Inc.
Healthcare | Biotechnology | USA
financial highlights | statements
Index- P/E- EPS (ttm)-0.82 Insider Own1.17% Shs Outstand13.92M Perf Week-6.78%
Market Cap6.49M Forward P/E- EPS next Y-1.03 Insider Trans0.00% Shs Float13.76M Perf Month-13.67%
Income-10.60M PEG- EPS next Q-0.14 Inst Own15.00% Short Float2.30% Perf Quarter-10.35%
Sales- P/S- EPS this Y2.30% Inst Trans16.06% Short Ratio0.49 Perf Half Y-10.50%
Book/sh0.54 P/B0.86 EPS next Y- ROA-97.50% Target Price1.00 Perf Year-67.85%
Cash/sh0.58 P/C0.80 EPS next 5Y- ROE-112.60% 52W Range0.45 - 1.95 Perf YTD-65.47%
Dividend- P/FCF- EPS past 5Y33.50% ROI- 52W High-76.09% Beta1.24
Dividend %- Quick Ratio8.60 Sales past 5Y- Gross Margin- 52W Low3.60% ATR0.04
Employees20 Current Ratio8.60 Sales Q/Q- Oper. Margin- RSI (14)35.31 Volatility7.56% 6.47%
OptionableNo Debt/Eq0.00 EPS Q/Q70.30% Profit Margin- Rel Volume0.39 Prev Close0.50
ShortableYes LT Debt/Eq0.00 EarningsNov 15 AMC Payout- Avg Volume645.78K Price0.47
Recom2.00 SMA20-10.73% SMA50-22.45% SMA200-20.45% Volume249,445 Change-7.68%
Feb-27-18Initiated Ascendiant Capital Markets Buy $2
Oct-09-13Initiated Dawson James Buy $3.75
Nov-14-18 04:30PM  ARCA biopharma Announces Third Quarter 2018 Financial Results and Provides Corporate Update GlobeNewswire -6.94%
Nov-12-18 08:30AM  GENETIC-AF Phase 2B Clinical Trial Atrial Fibrillation Burden (AFB) Results Presented at American Heart Association 2018 Scientific Sessions GlobeNewswire
Nov-05-18 08:30AM  ARCA Biopharma announces phase 2B GENETIC-AF atrial fibrillation burden (AFB) results selected for presentation at american heart association 2018 scientific sessions GlobeNewswire +13.17%
Oct-10-18 04:16PM  Westminster biotech company receives second extension on delisting notice from Nasdaq American City Business Journals -5.43%
Oct-02-18 08:00AM  Today's Research Reports on Trending Tickers: ARCA biopharma and Nektar Therapeutics ACCESSWIRE -35.29%
Sep-18-18 08:30AM  ARCA biopharma Submits Special Protocol Assessment Request to FDA for Gencaro Phase 3 Atrial Fibrillation Clinical Trial GlobeNewswire
Aug-09-18 04:15PM  ARCA biopharma Announces Second Quarter 2018 Financial Results and Provides Corporate Update GlobeNewswire
Aug-03-18 09:45AM  Marijuana Stocks: Biotech Stock Report: 3 Companies To Watch In August 2018 ACCESSWIRE
Jul-31-18 12:15PM  3 Biotech Stocks in Focus on Tuesday ACCESSWIRE
08:30AM  ARCA Biopharma Announces Positive Outcome of End-of-Phase 2 Meeting With FDA on Gencaro Development for Atrial Fibrillation GlobeNewswire
08:10AM  Todays Research Reports on Stocks to Watch: Progenics Pharmaceuticals and Arca Biopharma ACCESSWIRE
Jun-19-18 07:05AM  Breakfast Technical Briefing on Alkermes and Three Other Additional Biotech Stocks ACCESSWIRE
May-29-18 08:30AM  GENETIC-AF Phase 2B Clinical Trial Results Presented in Late Breaking Presentation at European Society of Cardiology Heart Failure 2018 World Congress GlobeNewswire -15.87%
May-11-18 08:20AM  Todays Research Reports on Stocks to Watch: vTv Therapeutics and ARCA Biopharma ACCESSWIRE -9.09%
May-10-18 08:30AM  ARCA biopharma Announces Phase 2B GENETIC-AF Clinical Trial Results Selected for Late Breaking Oral Presentation at European Society of Cardiology Heart Failure 2018 World Congress GlobeNewswire +14.37%
07:15AM  Free Technical Insights on Aimmune Therapeutics and Three More Biotech Stocks ACCESSWIRE
May-08-18 04:15PM  ARCA Biopharma announces first quarter 2018 financial results AND Provides Corporate Update GlobeNewswire
Apr-23-18 08:30AM  ARCA biopharma and Medtronic Extend Gencaro Clinical Trial Collaboration Agreement GlobeNewswire
Apr-03-18 07:20AM  Blog Exposure - Insmed Announced Submission of New Drug to FDA for Patients with Nontuberculous Mycobacterial Lung Disease ACCESSWIRE -5.17%
Mar-22-18 04:30PM  ARCA biopharma Announces Fiscal Year 2017 Financial Results and Provides Corporate Update GlobeNewswire
Feb-27-18 03:00PM  Heres Why Arca Biopharma Inc (ABIO) Shares Are Skyrocketing Today SmarterAnalyst +41.11%
Feb-26-18 02:18PM  ARCA biopharma And ObsEva Just Put Out Clinical Trial Data Market Exclusive -71.88%
08:00AM  ARCA biopharma Reports Topline Phase 2B Results for GENETIC-AF Clinical Trial GlobeNewswire
Jan-23-18 05:13PM  One Thing To Consider Before Buying ARCA biopharma Inc (NASDAQ:ABIO) Simply Wall St.
Jan-08-18 08:30AM  ARCA biopharma Announces Completion of GENETIC-AF Phase 2B Clinical Trial GlobeNewswire +10.00%
Jan-02-18 05:09PM  What You Must Know About ARCA biopharma Incs (NASDAQ:ABIO) Major Investors Simply Wall St.
Dec-08-17 06:13PM  Interested In Healthcare? Why ARCA biopharma Inc (ABIO) May Be The Entry Point Simply Wall St.
Nov-30-17 02:25PM  How Much is ARCA biopharma Incs (ABIO) CEO Getting Paid? Simply Wall St.
Nov-20-17 08:05AM  ARCA Biopharma, European Patent for Gencaro and Q3 Review ACCESSWIRE
Nov-17-17 08:10AM  Todays Research Reports on Stocks to Watch: ARCA biopharma and Amicus Therapeutics ACCESSWIRE
Nov-16-17 08:30AM  ARCA Biopharma Announces Issuance of European Patent for Treating Cardiovascular Diseases and Conditions With a New Chemical Entity Utilizing Genetic Targeting GlobeNewswire +20.83%
Nov-09-17 04:05PM  ARCA biopharma Announces Third Quarter 2017 Financial Results and Provides Business Update GlobeNewswire
Oct-23-17 08:16PM  ARCA biopharma Inc (ABIO): How Does It Impact Your Portfolio? Simply Wall St. +8.00%
Sep-21-17 08:30AM  ARCA biopharma to Present at the Sidoti & Company Fall 2017 Conference GlobeNewswire
Aug-16-17 08:30AM  ARCA biopharma Announces Completion of Enrollment for GENETIC-AF Phase 2B Clinical Trial GlobeNewswire
Aug-09-17 04:30PM  ARCA biopharma Announces GENETIC-AF Data and Safety Monitoring Board Recommendation to Complete Phase 2B GENETIC-AF Clinical Trial Based on Efficacy and Safety Data in Phase 2B Interim Analysis GlobeNewswire -6.85%
Aug-03-17 04:15PM  ARCA biopharma Announces Second Quarter 2017 Financial Results and Provides Business Update GlobeNewswire +7.89%
Jun-20-17 08:30AM  ARCA Biopharma Announces Database Lock for GENETIC-AF Phase 2B Interim Efficacy Analysis DSMB Recommendation Anticipated in August 2017 GlobeNewswire
May-15-17 08:30AM  ARCA Biopharma Announces First Quarter 2017 Financial Results and Provides Business Update GlobeNewswire
Apr-26-17 08:30AM  ARCA biopharma Announces 200th Patient Randomized into the GENETIC-AF Seamless Design Phase 2B/3 Clinical Trial Business Wire
Apr-18-17 08:30AM  ARCA biopharma to Present at the Planet MicroCap Showcase 2017 Investor Conference Business Wire
Mar-25-17 01:04PM  ARCA BIOPHARMA, INC. Financials
Mar-21-17 04:46PM  ARCA BIOPHARMA, INC. Files SEC form 8-K, Results of Operations and Financial Condition, Financial Statements and Exhi
04:30PM  ARCA biopharma Announces Fiscal Year 2016 Financial Results and Provides Business Update Business Wire
04:10PM  ARCA BIOPHARMA, INC. Files SEC form 10-K, Annual Report
Mar-06-17 04:32PM  ARCA BIOPHARMA, INC. Files SEC form 8-K, Other Events, Financial Statements and Exhibits
08:30AM  ARCA biopharma Announces 175th Patient Randomized into the GENETIC-AF Phase 2B/3 Clinical Trial Business Wire
Mar-01-17 04:47PM  ARCA BIOPHARMA, INC. Files SEC form 8-K, Change in Directors or Principal Officers
Feb-21-17 08:46AM  ARCA BIOPHARMA, INC. Files SEC form 8-K, Change in Directors or Principal Officers, Financial Statements and Exhibits
08:30AM  Anders Hove, MD Joins ARCA biopharma Board of Directors Business Wire
Jan-18-17 04:32PM  ARCA BIOPHARMA, INC. Files SEC form 8-K, Other Events, Financial Statements and Exhibits
08:30AM  ARCA biopharma Announces 150th Patient Randomized into the GENETIC-AF Phase 2B/3 Clinical Trial Business Wire
Jan-11-17 04:54PM  ARCA BIOPHARMA, INC. Files SEC form 8-K, Entry into a Material Definitive Agreement, Financial Statements and Exhibit
Jan-04-17 08:30AM  ARCA biopharma to Present at Biotech Showcase 2017 Business Wire
Dec-20-16 02:26PM  Hedge Funds Arent Crazy About A. M. Castle & Co (CASL) Anymore at Insider Monkey +10.64%
Nov-15-16 08:30AM  StockNewsNow.com Publishes New SNNLive Video Interview with ARCA biopharma, Inc. Provides Company Overview and Discusses Clinical Development PR Newswire
Nov-14-16 05:19PM  ARCA BIOPHARMA, INC. Files SEC form 8-K, Results of Operations and Financial Condition, Financial Statements and Exhi
05:08PM  ARCA BIOPHARMA, INC. Files SEC form 10-Q, Quarterly Report
04:15PM  ARCA biopharma Announces Third Quarter 2016 Financial Results and Provides Business Update Business Wire
Oct-06-16 04:07PM  ARCA BIOPHARMA, INC. Files SEC form 8-K, Other Events, Financial Statements and Exhibits
08:30AM  ARCA biopharma Announces Randomization of First European Patients in GENETIC-AF Phase 2B/3 Clinical Trial Business Wire
Oct-04-16 08:30AM  ARCA biopharma to Present at the Dawson James Securities Second Annual Growth Stock Conference Business Wire
Sep-13-16 09:00AM  ARCA biopharma Named Winner of Corporate LiveWire Healthcare and Lifesciences Innovation Award Business Wire
Aug-18-16 04:16PM  ARCA BIOPHARMA, INC. Files SEC form 8-K, Other Events, Financial Statements and Exhibits
08:30AM  ARCA biopharma Announces 100th Patient Randomized into the GENETIC-AF Phase 2B/3 Clinical Trial Business Wire
Aug-09-16 04:37PM  ARCA BIOPHARMA, INC. Files SEC form 8-K, Results of Operations and Financial Condition, Financial Statements and Exhi
04:30PM  ARCA biopharma Announces Second Quarter 2016 Financial Results and Provides Business Update Business Wire
Aug-03-16 01:37AM  Albioma :ABIO-FR: Earnings Analysis: For the six months ended June 30, 2016 : August 3, 2016
Jun-13-16 05:01PM  ARCA BIOPHARMA, INC. Files SEC form 8-K, Change in Directors or Principal Officers, Submission of Matters to a Vote o
May-11-16 04:57PM  ARCA BIOPHARMA, INC. Files SEC form 8-K, Results of Operations and Financial Condition, Financial Statements and Exhi
04:49PM  ARCA BIOPHARMA, INC. Files SEC form 10-Q, Quarterly Report
04:30PM  ARCA biopharma Announces First Quarter 2016 Financial Results and Provides Business Update Business Wire
Apr-18-16 04:31PM  ARCA BIOPHARMA, INC. Files SEC form 8-K, Other Events, Financial Statements and Exhibits
09:00AM  ARCA biopharma Announces 75th Patient Enrolled in GENETIC-AF Phase 2B/3 Clinical Trial Business Wire
Mar-17-16 04:44PM  ARCA BIOPHARMA, INC. Files SEC form 8-K, Results of Operations and Financial Condition, Financial Statements and Exhi
04:30PM  ARCA biopharma Announces Fiscal Year 2015 Financial Results and Provides Business Update Business Wire
04:14PM  ARCA BIOPHARMA, INC. Files SEC form 10-K, Annual Report
02:25PM  Bearish case for Valeant
Mar-07-16 04:32PM  ARCA BIOPHARMA, INC. Files SEC form 8-K, Entry into a Material Definitive Agreement, Financial Statements and Exhibit
Feb-16-16 04:41PM  ARCA BIOPHARMA, INC. Files SEC form 8-K, Change in Directors or Principal Officers
Jan-12-16 08:46AM  ARCA BIOPHARMA, INC. Files SEC form 8-K, Other Events, Financial Statements and Exhibits
08:30AM  GENETIC-AF Clinical Trial for Prevention of Atrial Fibrillation Enrolls 50th Patient Business Wire
Dec-08-15 09:00AM  Applying Lessons from KBIO Accesswire
Nov-30-15 09:38AM  2 Micro-Cap Opportunities in Atrial Fibrillation Accesswire
Nov-23-15 03:07PM  Biotechs Under 20 Dollars Poised to Breakout Accesswire
Nov-19-15 08:30AM  ARCA biopharma to Present at the 27th Annual Piper Jaffray Healthcare Conference Business Wire
Nov-18-15 09:42AM  2 Important Takeaways from ARCA Biopharma's Q3 Results Accesswire
Nov-12-15 04:43PM  ARCA BIOPHARMA, INC. Files SEC form 8-K, Results of Operations and Financial Condition, Financial Statements and Exhi
04:30PM  ARCA biopharma Announces Third Quarter 2015 Financial Results and Provides Business Update Business Wire
Nov-05-15 08:30AM  ARCA biopharma CEO Michael Bristow to Present in Two Sessions at the American Heart Association Scientific Sessions 2015 Business Wire
Nov-04-15 07:47AM  4 Stocks Under $10 Making Big Up Moves on Big Volume at TheStreet
Oct-20-15 02:08PM  Venrocks Latest Pick Shows There Are More Biotech Opportunities to Explore at Insider Monkey
Oct-19-15 09:28AM  Biotech Pullback: Look to Targeted Therapy Companies Accesswire
Oct-06-15 03:01PM  Biotechs take a beating
Sep-15-15 11:20AM  ARCA biopharma (ABIO): Leveraging Genetic Targeting to Better Treat Cardiovascular Disease Accesswire
Sep-09-15 04:06PM  ARCA BIOPHARMA, INC. Files SEC form 8-K, Other Events, Financial Statements and Exhibits
09:00AM  Gencaro Potential Efficacy Preventing Atrial Flutter in Heart Failure Paper to Be Presented at 2015 HFSA Annual Scientific Meeting Business Wire
Sep-03-15 04:32PM  ARCA BIOPHARMA, INC. Files SEC form 8-K, Amendments to Articles of Inc. or Bylaws; Change in Fiscal Year, Financial S
Aug-26-15 08:30AM  ARCA biopharma to Present at the Rodman & Renshaw 17th Annual Global Investment Conference Business Wire
Aug-13-15 08:10PM  10-Q for ARCA biopharma, Inc. at Company Spotlight
ARCA biopharma, Inc., a biopharmaceutical company, focuses on developing genetically-targeted therapies for cardiovascular diseases. The company's lead product candidate is Gencaro, a pharmacologically beta-blocker and mild vasodilator, which is in clinical trial for the treatment of atrial fibrillation in chronic heart failure patients with reduced left ventricular ejection fraction. It also engages in the development of a preclinical plan for AB171, a new chemical entity for the treatment of various cardiovascular indications, such as peripheral arterial disease and chronic heart failure. The company has a collaboration agreement with Medtronic, Inc. for the support of GENETIC-AF Phase 2B clinical trials; and Laboratory Corporation of America to provide the companion diagnostic test and services to support GENETIC-AF trial. ARCA biopharma, Inc. is headquartered in Westminster, Colorado.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Keuer Thomas AChief Operating OfficerApr 03Sale0.5048224213,153Apr 03 05:01 PM
Selby Brian L.VP, FinanceApr 02Sale0.501,1145560Apr 03 05:00 PM
Keuer Thomas AChief Operating OfficerFeb 28Sale0.7241029413,635Mar 01 05:01 PM
VENROCK HEALTHCARE CAPITAL PAR10% OwnerFeb 27Sale0.5341,33121,9050Feb 28 04:09 PM
Selby Brian L.VP, FinanceFeb 27Sale0.53161851,114Mar 01 05:00 PM
VENROCK HEALTHCARE CAPITAL PAR10% OwnerFeb 26Sale0.551,500,000825,00041,331Feb 28 04:09 PM
Sakoda Jon10% OwnerFeb 26Sale0.501,460,209731,2730Feb 27 04:37 PM
Sonsini Peter W.10% OwnerFeb 26Sale0.501,460,209731,2730Feb 27 04:38 PM
MOTT DAVID M10% OwnerFeb 26Sale0.501,460,209731,2730Feb 27 04:36 PM
SANDELL SCOTT D10% OwnerFeb 26Sale0.501,460,209731,2730Feb 27 04:37 PM
MAKOWER JOSHUA10% OwnerFeb 26Sale0.501,460,209731,2730Feb 27 04:36 PM
BARRIS PETER J10% OwnerFeb 26Sale0.501,460,209731,2730Feb 27 04:35 PM
BASKETT FOREST10% OwnerFeb 26Sale0.501,460,209731,2730Feb 27 04:35 PM
Florence Anthony A. Jr.10% OwnerFeb 26Sale0.501,460,209731,2730Feb 27 04:36 PM
Growth Equity Opportunities IV10% OwnerFeb 26Sale0.501,460,209731,2730Feb 27 04:34 PM
open in yahoo | open in reuters | open in google